Editas Medicine, Inc. (NASDAQ: EDIT) today announced the appointment of Jessica Hopfield, Ph.D., to its Board of Directors, effective immediately ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE